3-(4-(4-(3-Metilfenil)-1-piperazinil)butil)-2,4-imidazolidinedion

3-(4-(4-(3-Metilfenil)-1-piperazinil)butil)-2,4-imidazolidinedion
Nazivi
	Preferisani IUPAC naziv 3-[4-[4-(3-metilfenil)piperazin-1-il]butil]imidazolidin-2,4-dion
	Drugi nazivi 3-(4-(4-(3-metilfenil)-1-piperazinil)butil)-2,4-imidazolindion; CI 926; CI-926; PD 78787; PD-78787; 104683-52-5; CI 926; 3-(4-(4-(3-Metilfenil)-1-piperazinil)butil)-2,4-imidazolidinedion; 3-[4-[4-(3-metilfenil)piperazin-1-il]butil]imidazolidin-2,4-dion; UF97L75CUS; PD 78787; 2,4-Imidazolidinedion, 3-(4-(4-(3-metilfenil)-1-piperazinil)butil); CI-926; UNII-UF97L75CUS; SCHEMBL11067178; DTXSID50146649; AKOS034512249; PD162507; PD-78,787; Z649995780; 3-[4-[4-(3-metil-fenil)-1-piperazinil]butil]-2,4-imidazolinedion
Identifikacija
CAS broj	104683-52-5 ;
3D model (Jmol)	interaktivna slika;
PubChem C ID	128627;
UNII	UF97L75CUS ;
	SMILES CC1=CC(=CC=C1)N2CCN(CC2)CCCCN3C(=O)CNC3=O; ; ; ; ; ;
Svojstva
Hemijska formula	C18H26N4O2
Molarna masa	330,43 g·mol−1
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	Reference infokutije

3-(4-(4-(3-Metilfenil)-1-piperazinil)butil)-2,4-imidazolidinedion je antagonist alfa adrenergičkog receptora.^[3]

Reference

^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ R L Susick Jr; R A Jordan; J R Watkins (1991). „Cataracts in dogs following subchronic administration of the phenylpiperazine antihypertensive agent PD 78787”. Fundam Appl Toxicol. стр. 593—600. doi:10.1016/0272-0590(91)90209-m.